Last update :  15 Dec 2015

Kymab Ltd. received US Patent No. 9045548 B1, “Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment.”
Details : Link



Source Precision Medicine received US Patent No. 6692,16 “Systems and methods for characterizing a biological condition or agent using precision gene expression profiles.”
Details : Link


 

NuGen Technologies received US Patent 6692918 “Methods and compositions for linear isothermal amplification of polynucleotide sequences.”
Details : Link